What to know about malignant hyperthermia treatment

Medical note (because the internet is wild): This article is for general education, not personal medical advice. If you think someone is having a malignant hyperthermia (MH) crisis during anesthesia, treat it as an emergency and follow your facility’s MH protocol immediately.

Malignant hyperthermia sounds like “a really bad fever,” but it’s actually an anesthesia-triggered emergency where the body’s muscles go into metabolic overdrive. The good news: MH is treatablevery treatablewhen the team recognizes it quickly and gives the antidote (dantrolene) fast. The less-fun news: MH doesn’t respect “let’s just watch it for a minute” energy. When it shows up, it shows up like a surprise pop quiz that grades itself in real time.

This guide covers what MH treatment looks like in practice: the step-by-step playbook, the why behind each move, what happens after the crisis, and what MH-susceptible patients should know to stay safe for future surgeries.

First: what malignant hyperthermia is (and what it isn’t)

Malignant hyperthermia is a rare, life-threatening reaction most often triggered by certain general anesthesia gases (volatile inhaled anesthetics) and the paralytic drug succinylcholine. People who are susceptible typically have an inherited change affecting how skeletal muscle handles calcium (often involving the RYR1 gene, sometimes CACNA1S). When exposed to triggering drugs, muscle cells release too much calciummuscles contract hard, burn through energy, and generate heat and acid fast.

MH is not the same as:

• Regular postoperative fever from infection or inflammation (MH usually starts with rising CO₂ and muscle changes, and fever may come later).
• Heat stroke (overheating from environment/exertion), though there can be some overlap in muscle breakdown risk in certain people.
• Neuroleptic malignant syndrome (a reaction to certain psychiatric meds).
• Thyroid storm or severe sepsis (which can mimic parts of MH but require different primary treatment).

Why speed matters: what’s happening inside the body

Think of MH like a stuck accelerator in a high-performance engine. Skeletal muscles are suddenly told to “work” nonstop. That drives:

• Rapid CO₂ production (often an early clue in the OR).
• Metabolic and respiratory acidosis (blood becomes too acidic).
• Heat generation (hyperthermia can become dramaticbut it’s often a later sign).
• Rhabdomyolysis (muscle breakdown), which can cause high potassium and kidney injury.
• Arrhythmias and, if untreated, cardiac arrest.

Treatment works best when it targets the root problem (excess calcium-driven muscle hypermetabolism) and stabilizes the complications (acidosis, hyperkalemia, overheating, and organ strain).

Spotting an MH crisis: early clues you’ll hear before you “see” it

In real life, MH is often first suspected because the monitors start telling a story that doesn’t fit the script. Common early signals in an anesthetized patient include:

• Rising end-tidal CO₂ (ETCO₂) despite increasing ventilation.
• Tachycardia (fast heart rate) and sometimes unstable blood pressure.
• Muscle rigidityespecially jaw (masseter) rigidity after succinylcholine, or generalized rigidity that doesn’t match expected paralysis.
• Mixed acidosis on blood gas, rising lactate.
• Hyperkalemia and signs of muscle breakdown (dark urine, rising CK) as the crisis progresses.
• Rapid temperature rise can occur, but fever is often not the first sign.

If the pattern screams “this is not normal anesthesia physiology,” the safest move is to treat suspected MH immediatelybecause the downside of treating early is small compared with the downside of treating late.

The treatment playbook: what happens step-by-step

MH treatment is both simple (a clear protocol) and intense (a lot of actions at once). Most facilities keep an “MH cart” and a checklist for exactly this reason: nobody wants to do advanced pharmacology math while the patient’s CO₂ is trying to break the speed limit.

1) Stop triggers and call for help (fast, loudly, clearly)

• Stop volatile anesthetics (turn vaporizers off and remove them/disable per protocol).
• Stop succinylcholine (if it was given).
• Call for the MH cart and extra handsthis is a “team sport” emergency.
• Alert the surgeon so the procedure can be ended or paused safely as soon as feasible.

Many teams also call the MHAUS MH Hotline during a suspected crisis for real-time expert support (especially helpful if your facility doesn’t see MH often).

2) Give dantrolene: the specific antidote

Dantrolene is the cornerstone of malignant hyperthermia treatment. It works by reducing abnormal calcium release in skeletal muscle, which helps shut down the runaway metabolism. Standard emergency dosing is typically:

• Initial dose: 2.5 mg/kg IV as rapidly as possible.
• Repeat doses: repeat frequently as needed until signs improve (ETCO₂ falls, rigidity eases, heart rate stabilizes).
• Large cumulative doses: some patients need more than 10 mg/kg total, especially if rigidity/contractures persist.

Practical reality: the “hard part” isn’t knowing dantrolene existsit’s getting it mixed and pushed quickly. Different formulations have different mixing volumes, and that’s why stocking and drills matter. The faster dantrolene gets in, the better the odds of a smooth landing.

3) Hyperventilate with 100% oxygen

While dantrolene treats the cause, oxygenation and ventilation buy time and reduce CO₂/acidosis:

• 100% oxygen at high fresh gas flows.
• Increase minute ventilation to aggressively lower CO₂.

This is the “take your foot off the gas while the engine is still revving” part of the rescue.

4) Cool the patient (but don’t overshoot)

If the patient is hyperthermic, start active cooling:

• Cooling blanket, ice packs (groin/axilla/neck), chilled IV fluids per protocol.
• Consider more aggressive measures if temperature is dangerously high and rising.

Cooling is supportive care, not the curethink “fire extinguisher” while dantrolene shuts off the fuel source. Teams typically stop active cooling once temperature is trending down toward a safer range to avoid hypothermia.

5) Treat acidosis, hyperkalemia, and arrhythmias (the complication triad)

MH can create a perfect storm for the heart: acid, potassium, and stress hormones. Supportive treatment commonly includes:

• Acidosis: correct ventilation first; IV bicarbonate may be used depending on blood gas and protocol.
• Hyperkalemia: treatments may include IV calcium for membrane stabilization, insulin with glucose, beta-agonists (like albuterol), and other measures based on severity.
• Arrhythmias: treat per ACLS/anesthesia protocols, but avoid calcium channel blockers during an MH crisis when dantrolene is being used due to the risk of severe hyperkalemia and cardiovascular collapse.

The “avoid calcium channel blockers” rule is one of those lifesaving footnotes people remember foreverbecause it’s the kind of detail that matters exactly when your brain is busiest.

6) Protect the kidneys and manage muscle breakdown

Muscle breakdown (rhabdomyolysis) can flood the bloodstream with potassium and myoglobin. To help prevent kidney injury, teams often:

• Give IV fluids to maintain strong urine output.
• Monitor urine color and labs (CK, creatinine, electrolytes).
• Use urine alkalinization strategies in some protocols if myoglobinuria is suspected.

Translation: you’re not just treating a crisisyou’re preventing the “sequel” where the crisis damages organs after the initial fire is out.

7) Monitor for recurrence and transfer to higher-level care

MH can recur after initial stabilization (recrudescence), which is why post-crisis care often includes:

• ICU monitoring for at least 24 hours (often longer if severe).
• Maintenance dantrolene (commonly 1 mg/kg IV every 4–6 hours, or per protocol) until the patient is stable and labs/trends are reassuring.
• Serial labs: blood gases, electrolytes, CK, kidney function, coagulation tests, and temperature/ETCO₂ trends.

This is the part where the adrenaline wears off and the checklist earns its keep.

What happens after an MH crisis

Documentation, reporting, and future-proofing

After the patient is stable, the care team typically documents the event in detail: suspected triggers, timeline, key vitals and lab changes, total dantrolene dose, and complications treated. This information is crucial because it directly affects future anesthesia choices.

Many teams also guide patients toward follow-up evaluation for MH susceptibility, including specialty referral, potential genetic counseling/testing, and/or confirmatory muscle testing when appropriate.

If you’re MH-susceptible: safe anesthesia is still possible

A diagnosis (or strong suspicion) of MH susceptibility does not mean “no surgeries ever.” It means “no triggering agents.” Anesthesia teams can use trigger-free approaches safely, including:

• Total intravenous anesthesia (TIVA) using non-triggering medications.
• Regional anesthesia (spinal/epidural/nerve blocks) when appropriate.
• Non-triggering sedatives and pain control as clinically indicated.

Why anesthesia machine prep matters

Even if the team avoids triggers, anesthesia machines can retain trace amounts of volatile anesthetics. Facilities follow protocols to prepare machines for MH-susceptible patientsoften involving disabling/removing vaporizers, changing circuits/CO₂ absorbent, high fresh-gas flushes, and in many settings, activated charcoal filters to speed the process.

This is one reason MH planning is ideally done before the day of surgeryso nobody is scrambling to “de-gas” a machine while the clock is ticking.

Testing and family implications: CHCT and genetic testing

If MH susceptibility is suspected, two main testing pathways are commonly discussed:

• Muscle biopsy contracture testing (CHCT in North America): historically considered the standard diagnostic test. It requires referral to specialized centers and is not typically performed in very young children.
• Genetic testing: can identify known pathogenic variants (often in RYR1 or CACNA1S), which can help guide family screening. A negative genetic test does not always rule out susceptibility, because not every causative variant is known or captured on every panel.

Because MH is often inherited in an autosomal dominant pattern, identifying susceptibility can matter for parents, siblings, and children. In plain English: if you have it, your relatives may want to knowbecause it changes anesthesia planning in a very actionable way.

FAQ: quick answers people actually ask

Is malignant hyperthermia the same as a high fever?

No. Fever can happen, but MH is a hypermetabolic muscle crisis triggered by specific anesthetic agents. Rising CO₂, tachycardia, rigidity, acidosis, and hyperkalemia often show up before the temperature becomes dramatic.

What’s the most important treatment?

Dantrolene, plus stopping triggers and aggressive supportive care (oxygenation/ventilation, cooling, correcting acidosis/hyperkalemia, and ICU monitoring).

Can MH happen after surgery is over?

Yes. MH can present during anesthesia or in the early postoperative period, and recurrence can occur after initial stabilizationhence extended monitoring and maintenance dantrolene in many protocols.

If someone in my family had MH, does that mean I will?

Not automatically, but it raises concern for inherited susceptibility. The safest approach is to tell your surgical/anesthesia team and ask about referral for evaluation/testing. In the meantime, anesthesia can be planned using non-triggering agents.

Experiences that stick with people (about )

When clinicians talk about malignant hyperthermia later, they rarely start with the lab values. They start with the moment the room changed. One minute it’s a routine case: quiet music, a steady rhythm of monitors, people thinking about lunch. The next minute, the ETCO₂ creeps up, the heart rate follows, and someone says the sentence that makes every anesthesia provider sit up straighter: “This isn’t responding like it should.”

A common theme in MH stories is that it doesn’t announce itself with a neon sign reading “MALIGNANT HYPERTHERMIA HERE!” It’s more like a mystery novel where the clues are subtleuntil they aren’t. People remember realizing that turning up ventilation didn’t fix the CO₂, or that jaw rigidity after succinylcholine felt “off,” or that the patient’s temperature was rising faster than physiology has any right to rise. And then the best part of the story happens: the protocol kicks in.

The MH cart shows up. Roles get assigned without anyone holding a meeting about it. Someone calls out dantrolene dosing; someone else starts reconstituting vials like they’re auditioning for a speed-mixing competition. A nurse reads the checklist out loud. The surgeon pivots from “finish the case” to “finish safely.” It’s intense, but it’s also oddly orderlybecause MH is one of those emergencies where preparation pays off instantly.

In debriefs, teams often mention that the hardest part isn’t knowing what to doit’s doing it fast enough when multiple problems are happening at once. Dantrolene is the star, but it needs a supporting cast: cooling measures that don’t overshoot, hyperkalemia treatment that’s timely, labs drawn and repeated, a plan for ICU transfer, and a watchful eye for recurrence. People also remember the “small big things,” like making sure sterile water is in the same drawer as the dantrolene, or that everyone knows where the protocol is stored when Wi-Fi decides to be dramatic.

Patients and families, on the other hand, often describe MH as the moment they learned the word “susceptibility.” Many don’t remember the crisis itself (anesthesia has that effect), but they remember the follow-up: being told to wear medical alert identification, to mention MH at every future surgery, and to encourage relatives to get evaluated. Some describe a strange reliefbecause scary as MH is, it’s also unusually actionable. You can’t change your genes, but you can absolutely change which drugs you receive, and that change is powerful.

If there’s a single “experience lesson” that comes up again and again, it’s this: malignant hyperthermia treatment works best when it’s treated like a fire drillpracticed, stocked, and immediate. The protocol turns panic into steps, and steps into survival. It’s not glamorous. It’s not funny in the moment. But afterward, many teams say the same thing with a mix of pride and exhaustion: “The checklist did exactly what it was supposed to do.”